Results of clinical research published19 Sep 2022:
Clinical Perspective
What Is New?
In a cohort study of 48 million adults in England and Wales, COVID-19 was associated with substantial excess incidence of both arterial thromboses and venous thromboembolism, which declined with time from COVID-19 diagnosis.
Excess incidence was higher, for a longer time, after hospitalized than non-hospitalized COVID-19.
There were an estimated 10 500 excess arterial thromboses and venous thromboembolic events after 1.4 million COVID-19 diagnoses.
What Are the Clinical Implications?
Strategies to prevent vascular events after COVID-19 are particularly important after severe COVID-19 leading to hospitalization and should include an early review in primary care and risk factor management.
After severe COVID-19, individuals at high risk of vascular events should be prescribed preventive therapies and counseled about the importance of adherence to them.
New simple treatment strategies to reduce infection-associated venous thromboembolism and arterial thromboses are needed.
Rochelle Knight, Venexia Walker, Samantha Ip, and others
No comments:
Post a Comment